Answers are grounded in this paper and cite their sources.
The addition of nelarabine to ABFM therapy improved DFS for children and young adults with newly diagnosed T-ALL without increased toxicity.
No takes yet. Share an insight, caveat, or question.
Dunsmore et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: